AboutBlogOver 40,000+ FDA inspection documents: 483s, EIRs, 483Rs

483 Sun Pharmaceutical Industries (prev. Ranbaxy Toansa), Jan 2014

$119 - Available for instant download

FDA investigators audited the Sun Pharmaceutical Industries (prev. Ranbaxy Toansa) - Punjab, India facility and issued 8 inspectional observations (via FDA 483) on 11 Jan 2014.

Product Details

  • Category: Human Drugs
  • Number of Observations: 8
  • Inspection end: 11 Jan 2014
  • Location: Punjab, India
  • FEI: 3002807972
Sun Pharmaceutical Industries (prev. Ranbaxy Toansa) FDA inspection 483 Jan 2014

Related Products